Summary of the safety profile: Meropenem-related adverse reactions most frequently reported were diarrhoea, rash, nausea/vomiting and injection site inflammation. The most commonly reported meropenem-related laboratory adverse events were thrombocytosis and increased hepatic enzymes. (See Table 4.)
Click on icon to see table/diagram/image
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.